Gufic BioSciences Ltd

NSE: GUFICBIO · BSE: 509079 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹422.55
Market cap: ₹4,237 Cr
Revenue (annual): ₹944.0 Cr
Net profit (annual): ₹64.21 Cr
P/E (TTM): 57.7×Sector 47.3×
Promoter holding: 72.50%+0.00% QoQ
FII holding: 0.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 4 Acquisition 4 Other Announcement 3 Merger & Restructuring 3 Management Change 2 Legal & Regulatory 2 Board Meeting Outcome 2 Board Meeting Date 2 Annual General Meeting 2 Dividend 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

31 Jul 2026 19:33 IST NSE

Board Meeting Outcome

Gufic BioSciences Board Meeting Outcome

Gufic Biosciences' Board approved the re-appointment of Mr. Pankaj Jayakumar Gandhi as Whole Time Director for a 5-year term, effective September 7, 2026.

Read the filing ↗

29 May 2026 22:58 IST NSE

Board Meeting Outcome

Gufic BioSciences Board Meeting Outcome

Gufic Biosciences appointed Mrs. Saroj R. Kirdolia as Internal Auditor and re-appointed M/s. Poddar & Co. as Cost Auditor. Both appointments cover the Financial Year 2026-27.

Execution: Financial Year 2026-27

Read the filing ↗